Bristol’s Yervoy Adds Up to 10 Years of Life for Cancer Patients
Bristol’s Yervoy Adds Up to 10 Years of Life for Cancer Patients Bloomberg
View ArticleYervoy Battles Melanoma, but Can It Become a Blockbuster?
Yervoy Battles Melanoma, but Can It Become a Blockbuster? Motley Fool
View ArticleMerck Faces Off Against Bristol-Myers' Yervoy
Merck Faces Off Against Bristol-Myers' Yervoy Motley Fool
View ArticlePfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy Seeking Alpha
View ArticleBristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race Seeking Alpha
View ArticleGalectin announces IND filed to study GR-MD-02 in combination with Yervoy
Galectin announces IND filed to study GR-MD-02 in combination with Yervoy Yahoo/Fly on the Wall
View ArticleMerck hits a new high as analyst sees opening for new cancer drug
Merck hits a new high as analyst sees opening for new cancer drug Marketwatch
View Article6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014 Seeking Alpha
View ArticleFrantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers Seeking Alpha
View ArticleImmune Checkpoint Blocker Race Heats Up
Immune Checkpoint Blocker Race Heats Up Wall St Cheat Sheet
View ArticleBristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment
Bristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment Marketwatch
View ArticleFour Upcoming Catalysts That Could Move Pharmaceutical Stocks
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks Yahoo/24-7 Wall St
View ArticleImmune Therapy’s Cancer Promise Creates Research Rush
Immune Therapy’s Cancer Promise Creates Research Rush Bloomberg
View ArticleU.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors
U.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors Yahoo/Reuters
View ArticleBristol Defends Data; Roche Shines In Cancer Showdown
Bristol Defends Data; Roche Shines In Cancer Showdown Investors.com
View ArticleASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy Yahoo/Benzinga
View ArticleBristol Shares Sag On Cancer Drug Worries
Bristol Shares Sag On Cancer Drug Worries Forbes
View ArticleBristol-Myers Squibb's Oncology Opportunity
Bristol-Myers Squibb's Oncology Opportunity Motley Fool
View Article
